Top Markets
#1 Akedo Akedo +61.14%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.20%
#4 Cross Cross +47.31%
#5 Black Phoenix Black Phoenix +34.31%
#6 Velvet Velvet +29.27%
#7 OVERTAKE OVERTAKE +25.19%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.05%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.98%
#10 Movement Movement +14.11%
Coin of the day
Akedo Akedo
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Kedudukan dalam Saham #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Harga Saham
$0.02243487
Disegerakkan terakhir: 2025-06-04
Modal Pasaran
$650.09K
Perubahan (1 hari)
0.39%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Lipidor AB (publ) (LIPI)

Kategori

Healthcare
Bilangan saham terbitan bagi Lipidor AB (publ) (LIPI)
Bilangan saham terbitan setakat December 2024: 251.84M
Menurut laporan kewangan terkini dan harga saham Lipidor AB (publ), bilangan saham terbitan semasa ialah 251.84M. Pada akhir December 2023, syarikat mempunyai 28.98M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Lipidor AB (publ) (LIPI) dari 2016 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 251.84M -41.77%
2024 432.53M 1,392.66%
2023 28.98M 0.00%
2022 28.98M 1.83%
2021 28.45M 15.77%
2020 24.58M 21.63%
2019 20.21M 11.87%
2018 18.06M 0.00%
2017 18.06M 0.00%
2016 18.06M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M 254.35%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B 868.92%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 603.22%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M 216.07%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US